- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
A funny thing happened on the way to the forum
Today was the kind of day I like at the RSNA meeting. I reviewed some old stuff, learned some new stuff, and had some great laughs.
Today was the kind of day I like at the RSNA meeting. I reviewed some old stuff, learned some new stuff, and had some great laughs.
I attended two very good courses, both part of the society's "Essentials of Radiology" program. These courses provide basic core material in a quick but thorough overview. I went to the pediatric and knee sessions. These are facts we should all have on the tips of our tongues, and now I will have them again for at least a day or two.
I spent several hours side-stepping the poster exhibit hall. Every year, I promise myself that next year I will spend the entire week in that hall. Where else can you study the latest information on any current topic in radiology, concisely and graphically presented, at your own pace?
There were several excellent presentations on CT brain perfusion imaging, a technique we're adding to our routine R/O stroke protocol. I saw a little poster comparing enhanced with nonenhanced abdominal CT on ER patients, which confirmed my belief that most (80%) of the time you should just go ahead and scan them, rather than delay them for IV and oral contrast. And while I never really thought about doing CT on a possum, now I know how.
I spent a couple of hours looking at the vendor exhibits. We're in the market for a new multislice CT, and like most radiologists, I have slice envy. Toshiba, GE, Philips, and Siemens all claim they're the best. They all look pretty good to me, but then I trained on an EMI.
There are a lot of exhibits for mammography equipment, software and promotional material. I find this interesting, since I don't know any radiologist in the universe who wants to do more mammo.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.
